글로벌 골관절염 통증 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 골관절염 통증 시장

골관절염 통증 시장은 2021년에서 2028년까지의 예측 기간 동안 6.90%의 시장 성장을 목격할 것으로 예상됩니다. 골관절염 통증 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 의료 서비스를 개선하기 위한 다양한 인식 프로그램과 이니셔티브에 대한 당국의 초점이 커지면서 골관절염 통증 시장의 성장이 가속화되고 있습니다.

골관절염 통증은 일반적으로 퇴행성 뼈 질환이라고 불리는 골관절염을 치료하기 위해 의도된 여러 가지 치료 및 의학적 방법을 사용하는 것으로 알려져 있습니다. 이것은 가장 흔한 관절염 형태이며 관절의 끊임없는 마모와 함께 일반적으로 널리 퍼져 있으며 뼈 사이의 연골 쿠션이 일정 기간 동안 분해될 때 인기가 있습니다. 

예측 기간 동안 골관절염 통증 시장 의 성장을 촉진할 것으로 예상되는 주요 요인은 전 세계 노인 인구의 증가입니다. 또한 전 세계적으로 질병의 발병률이 증가하고 있습니다. 반면, 약물의 여러 부작용과 관련된 어려움은 타임 라인 기간 동안 골관절염 통증 시장의 성장을 더욱 방해할 것으로 예상됩니다.

또한, 질병 및 기타 의료 서비스에 대한 치료 및 치료제 의 저렴성 증가는 향후 몇 년 동안 골관절염 통증 시장의 성장에 대한 잠재적 기회를 더욱 제공할 것입니다. 그러나 증상 관리를 위한 치료제의 접근성은 가까운 미래에 골관절염 통증 시장의 성장에 더욱 도전이 될 수 있습니다.

This osteoarthritic pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the osteoarthritic pain market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Global Osteoarthritic Pain Market Scope and Market Size

The osteoarthritic pain market is segmented on the basis of disease type, diagnosis, treatment type, drug class, route of administration, dosage form, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

• On the basis of disease type, the osteoarthritic pain market is segmented into hip, wrist, spinal and finger joints.
• On the basis of diagnosis, the osteoarthritic pain market is segmented into magnetic resonance imaging (MRI) and X-rays.
• On the basis of treatment type, the osteoarthritic pain market is segmented into medication, surgery and therapy. Medication is further sub segmented into analgesics and non-steroidal. Therapy is further sub segmented into non-pharmacological and pharmacological.
• On the basis of drug class, the osteoarthritic pain market is segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, viscosupplements, corticosteroids, others.
• On the basis of route of administration, the osteoarthritic pain market is segmented into oral and non-oral. Non-oral is further sub segmented into topical and parenteral.
• On the basis of dosage form, the osteoarthritic pain market is segmented into solid, liquid, semi-solid.
• On the basis of application, the osteoarthritic pain market is segmented into hospitals, clinics, medical institutes, research institutes, pharmacy, others.
• On the basis of end user, the osteoarthritic pain market is segmented into professional care, home care.

Osteoarthritic Pain Market Country Level Analysis

The osteoarthritic pain market is analyzed, and market size insights and trends are provided by country, disease type, diagnosis, treatment type, drug class, route of administration, dosage form, application and end user as referenced above.      

The countries covered in the osteoarthritic pain market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the osteoarthritic pain market due to the changes in the lifestyles. Furthermore, the increase in the healthcare expenses will further boost the growth of the osteoarthritic pain market in the region during the forecast period. Asia-Pacific obtainability of funds for research. Moreover, the large patient population and increase in healthcare costs are further anticipated to propel the osteoarthritic pain market in the region in the coming years.

The country section of the osteoarthritic pain market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The osteoarthritic pain market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the osteoarthritic pain market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the osteoarthritic pain market. The data is available for the historic period 2010-2019.

Competitive Landscape and Osteoarthritic Pain Market Share Analysis

The osteoarthritic pain market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the osteoarthritic pain market.

골관절염 통증 시장 보고서에 포함된 주요 기업으로는 Abbott, Medical Devices Business Services, Inc., Novartis AG, Pfizer Inc., Abiogen Pharma Spa, Merck KGaA, Crystal Genomics Inc., Cytori Therapeutics Inc., GlaxoSmithKline plc., Mylan NV, Sanofi, Bayer AG, ALMATICA PHARMA LLC., Teva Pharmaceutical Industries Ltd., Iroko Pharmaceuticals, LLC, AstraZeneca, Boehringer Ingelheim International GmbH 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-50210